Form 8-K - Current report:
SEC Accession No. 0000875320-24-000231
Filing Date
2024-12-20
Accepted
2024-12-20 15:51:45
Documents
13
Period of Report
2024-12-20
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K vrtx-20241220.htm   iXBRL 8-K 22285
  Complete submission text file 0000875320-24-000231.txt   145679

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20241220.xsd EX-101.SCH 1870
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20241220_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20241220_pre.xml EX-101.PRE 12595
16 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20241220_htm.xml XML 2720
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 241567791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)